Danaher (DHR)
(Delayed Data from NYSE)
$190.46 USD
-2.83 (-1.46%)
Updated Sep 22, 2025 04:00 PM ET
After-Market: $190.46 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Danaher Corporation has a market cap of $139.82B, which represents its share price of $195.27 multiplied by its outstanding shares number of 716.05M. As a large-cap company, DHR's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DHR 190.46 -2.83(-1.46%)
Will DHR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DHR
Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
DHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
Danaher Gains From Business Strength Amid Persisting Headwinds
Other News for DHR
Danaher price target lowered to $220 from $230 at BofA
Danaher price target lowered by $10 at BofA, here's why
Danaher (DHR) Receives a Buy from Bank of America Securities
B of A Securities Adjusts Danaher (DHR) Price Target to $220 | DHR Stock News
DHR's price falls by 1.02% on September 20, though its technical setup remains stable.